Company / Free Cash Flow per Share
Entera Bio Ltd. Free Cash Flow per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$0.18
FY2025
5-year range
-$0.50 / -$0.18
FY2021-FY2025
Trend
+15.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $-0.44 to $-0.18 over the past 2 years.
Based on SEC 10-K filings.
-0.18 in FY2025.
Improved from $-0.44 to $-0.18 over the past 2 years.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, free cash flow per share increased 15.0% year-over-year.
- Lowest free cash flow per share in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score -0.83 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.18 | +15.0% |
| FY2024 | -$0.21 | +52.6% |
| FY2023 | -$0.44 | -38.1% |
| FY2022 | -$0.32 | +37.4% |
| FY2021 | -$0.50 | - |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026